Evidence map›Paper›PMID 25694528›Full record

ArticleJournal of clinical microbiology2015

Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis.

Denis Filisetti, Hélène Yera, Odile Villard, Benoît Escande, Estelle Wafo, Véronique Houfflin-Debarge, Laurence Delhaes, Patrick Bastien

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Molecular diagnosis of human toxoplasmosis: the state of the art.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Denis FilisettiLaboratoire de Parasitologie et Mycologie Médicale, Les Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France Pôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Centre Hospitalier Universitaire of Montpellier, Montpellier, France.
Hélène YeraLaboratoire de Parasitologie Mycologie, Hôpital Cochin, Hôpitaux Universitaires Paris Centre AP-HP, Université Paris Descartes, Paris, France Pôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Centre Hospitalier Universitaire of Montpellier, Montpellier, France helene.yera@cch.aphp.fr.
Odile VillardLaboratoire de Parasitologie et Mycologie Médicale, Les Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
Benoît EscandeService de Pédiatrie 2, Les Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.
Estelle WafoGynécologie-Obstérique, Centre Hospitalier de Marne-La-Vallée, Jossigny, France.
Véronique Houfflin-DebargeGynécologie-Obstérique, Université Lille Nord de France (UDSL), CHRU de Lille, Lille, France.
Laurence DelhaesLaboratoire de Parasitologie Mycologie, EA4547-BDEEP, CIIL, Faculté de Médecine, Université Lille Nord de France (UDSL), CHRU de Lille, Lille, France Pôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Centre Hospitalier Universitaire of Montpellier, Montpellier, France.
Patrick BastienLaboratoire de Parasitologie-Mycologie, CHU (University Hospital Centre) of Montpellier, UMR MIVEGEC CNRS 5290/IRD 224/University of Montpellier, Montpellier, France Pôle Biologie Moléculaire du Centre National de Référence de la Toxoplasmose, Centre Hospitalier Universitaire of Montpellier, Montpellier, France.
Centre Hospitalier Universitaire de Montpellier · FRUniversité de Strasbourg · FRCentre Hospitalier Universitaire de Lille · FRUniversité de Montpellier · FRUniversité Lille Nord de France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the molecular diagnosis of congenital toxoplasmosis (CT) on neonatal amniotic fluid samples from 488 mother-child pairs. Maternal infection during pregnancy was diagnosed and dated or could not be ruled out. Forty-six cases of CT were defined according to the European Research Network on CT classification system and case definitions. Neonatal amniotic fluid testing had an overall sensitivity of 54% (95% confidence interval [95% CI], 39 to 69%) and a specificity of 100% (95% CI, 99 to 100%). Its sensitivity was 33% (95% CI, 13 to 59%) when antenatal diagnosis was positive and 68% (95% CI, 48 to 84%) when antenatal diagnosis was negative or lacking. This difference in sensitivity may have been due to treatment of antenatally diagnosed cases. Relative to postnatal serology, neonatal amniotic fluid testing allowed an earlier diagnosis to be made in 26% of the cases (95% CI, 9 to 51%).

Indexed as

Amniotic FluidFemaleHumansInfant, NewbornMolecular Diagnostic TechniquesPolymerase Chain ReactionPregnancySensitivity and SpecificityTime FactorsToxoplasmosis, Congenital

Identifiers

PMID25694528
PMCPMC4400781
OpenAlexW2167725183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.